Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02018263 · ClinicalTrials.gov registry record · Phase 1
Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans
A Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT02018263 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 5 participants.
The verdict
NCT02018263, a Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study looks to explore the feasibility, sensitivity, validity, and specificity of a Remote Wireless Sensor Network (RWSN) approach to the detection of cocaine use/intoxication in the inpatient human laboratory, as well as in the outpatient setting ("real world"). Lastly, we look to design an algorithm for reliably detecting cocaine use in real-world settings and inference techniques for understanding the relationship between cocaine use and user contexts.
Interventions
- BEHAVIORAL Exercise
- DRUG Nicotine
- DRUG Cocaine hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02018263
The ClinicalTrials.gov registry entry for NCT02018263 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Exercise is the first listed.
NCT02018263 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02018263 about?
NCT02018263 is a clinical study titled "Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans". This study looks to explore the feasibility, sensitivity, validity, and specificity of a Remote Wireless Sensor Network (RWSN) approach to the detection of cocaine use/intoxication in the inpatient human laboratory, as well as in the outpatient setting ("real world"). Lastly, we look to design an al...
What is the current status of trial NCT02018263?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2013-10. Estimated completion is 2014-06.
What interventions are being tested in trial NCT02018263?
The interventions under investigation include: Exercise (BEHAVIORAL), Nicotine (DRUG), Cocaine hydrochloride (DRUG).
Who is sponsoring clinical trial NCT02018263?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.